Yifeng Pharmacy Chain Co Ltd banner

Intrinsic Value

The intrinsic value of Yifeng Pharmacy Chain Co Ltd (603939) under the Base Case is 24.49 CNY per share. Compared with the current market price of 25.57 CNY, the stock appears Overvalued by 4% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

Intrinsic Value
¥24.49
Overvaluation 4%
Intrinsic Value
Price ¥25.57

Yifeng Pharmacy Chain Co Ltd is valued in line with its history. A premium of this size has been typical over the past 5 years.

Monitor Yifeng Pharmacy Chain Co Ltd
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value ¥19.59
Get notified when the price drops into your buy zone
Current Price ¥25.57
Intrinsic Value ¥24.49
Margin of Safety 20% ¥19.59
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to Yifeng Pharmacy Chain Co Ltd

Fundamental Analysis

What Yifeng Pharmacy Chain Does

Retail Consumer Staples

Yifeng Pharmacy Chain Co Ltd runs a retail pharmacy network in China. It sells prescription medicines, over-the-counter drugs, health supplements, medical devices, personal care items, and other daily health products through its stores and online channels. Its main customers are ordinary consumers, patients who need ongoing medication, and people looking for convenient neighborhood health products and advice.

Headquarters
China CN
Employees
38 953
IPO date
Feb 17, 2015
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Yifeng Pharmacy Chain Co Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one Yifeng Pharmacy Chain Co Ltd stock?

The intrinsic value for Yifeng Pharmacy Chain Co Ltd (603939) under the Base Case is 24.49 CNY.

Is Yifeng Pharmacy Chain Co Ltd stock undervalued or overvalued?

Compared with the current market price of 25.57 CNY, the stock appears Overvalued by 4% .

Back to Top